NCT07102251View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Healthy Subjects
Interventions
DRUG

HEC-007 injection

Single dose escalation of HEC-007 injection in healthy subjects

DRUG

Placebo

Single dose of placebo in healthy adults

DRUG

HEC-007 injection

Multiple dose escalation of HEC-007 injection in Overweight or Obese Subjects

DRUG

Placebo

Multiple dose of placebo in Overweight or Obese Subjects

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY